Literature DB >> 2415075

Fertility and hormonal function in patients with a nonseminomatous tumor of the testis.

J M Nijman, H Schraffordt Koops, J Kremer, P H Willemse, D T Sleijfer, J Oldhoff.   

Abstract

Semen quality and serum testosterone, LH, and FSH levels were studied in 54 patients with a unilateral nonseminomatous tumor of the testis--14 before and 40 after orchiectomy. Semen analyses before and after orchiectomy gave essentially no different results: a poor semen quality was found in most men. The additional effect of a recent orchiectomy on semen quality was not demonstrable in the patients described here. Before orchiectomy, increased testosterone levels were found in patients with a beta-hCG-producing tumor. After orchiectomy serum testosterone levels were decreased, and LH and FSH levels increased. With beta-hCG-producing tumors FSH was suppressed after orchiectomy, and testosterone levels did not exceed those in patients with a tumor not producing beta-hCG. The results of semen analysis and of hormonal studies after orchiectomy suggest a dysfunction of the remaining "normal" testis. Diminished spermatogenesis and insufficient testosterone production by the Leydig cells clearly indicate anomalies already present before orchiectomy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2415075     DOI: 10.3109/01485018508988306

Source DB:  PubMed          Journal:  Arch Androl        ISSN: 0148-5016


  8 in total

Review 1.  Effects of cancer and anti-neoplastic treatment on the human testicular function.

Authors:  A De Palma; E Vicari; I Palermo; R D'Agata; A E Calogero
Journal:  J Endocrinol Invest       Date:  2000-11       Impact factor: 4.256

2.  Effects of anti-neoplastic treatment on sperm aneuploidy rate in patients with testicular tumor: a longitudinal study.

Authors:  N Burrello; E Vicari; S La Vignera; G Romeo; C Campagna; E Magro; D Giuffrida; R D'Agata; A E Calogero
Journal:  J Endocrinol Invest       Date:  2010-07-29       Impact factor: 4.256

Review 3.  Anticancer chemotherapeutic agents and testicular dysfunction.

Authors:  Kohei Yamaguchi; Masato Fujisawa
Journal:  Reprod Med Biol       Date:  2011-03-17

Review 4.  The Association Between Testis Cancer and Semen Abnormalities Before Orchiectomy: A Systematic Review.

Authors:  Hooman Djaladat; Elizabeth Burner; Pooja M Parikh; Dorsa Beroukhim Kay; Krystal Hays
Journal:  J Adolesc Young Adult Oncol       Date:  2014-12-01       Impact factor: 2.223

5.  Risk of testicular cancer in men with abnormal semen characteristics: cohort study.

Authors:  R Jacobsen; E Bostofte; G Engholm; J Hansen; J H Olsen; N E Skakkebaek; H Moller
Journal:  BMJ       Date:  2000-09-30

6.  Case Studies in Polar Bear (Ursus maritimus) Sperm Collection and Cryopreservation Techniques.

Authors:  Jessye Wojtusik; Terri L Roth; Erin Curry
Journal:  Animals (Basel)       Date:  2022-02-11       Impact factor: 2.752

7.  Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer.

Authors:  M Brydøy; S D Fosså; O Klepp; R M Bremnes; E A Wist; T Bjøro; T Wentzel-Larsen; O Dahl
Journal:  Br J Cancer       Date:  2012-11-20       Impact factor: 7.640

Review 8.  Fertility preservation of patients with testicular cancer.

Authors:  Itsuto Hamano; Shingo Hatakeyama; Chikara Ohyama
Journal:  Reprod Med Biol       Date:  2017-05-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.